Bioinvent International AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioinvent International AB with three other
companies in this sector in Sweden:
sales of 48.00 million Swedish Kronor [US$5.39 million]
(36.64 million Swedish Kronor [US$4.11 million]
of which 100%
was Pharmaceutical), and
Alligator Bioscience Ab
(56.88 million Swedish Kronor [US$6.38 million]
Bioinvent International AB reported sales of SEK 45.01 million (US$5.05 million)
December of 2017.
decrease of 36.9%
versus 2016, when the company's sales were SEK 71.28 million.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Bioinvent International AB had sales
of SEK 42.95 million.